News
Student-led symposium helps build research connections across KU and the region
Five years ago, a group of KU researchers and trainees set out to create something more than a scientific conference. ...
KU receives $5.8 million NIH Phase 3 COBRE funding for Chemical Biology of Infectious Disease center
As antibiotic resistance makes everyday infections tougher to treat and emerging pathogens drive challenging infectious-disease outbreaks, researchers in Kansas from multiple disciplines and institutions are teaming up to target pathogens and overcome antibiotic resistance. ...
October Lunch & Learn: Inside KU CBID Core Labs
October Lunch & Learn: Inside KU Core Labs...
Orozco receives new KUCC Spring Pilot Grant
Dr. Robin Orozco received a new KUCC Spring Pilot FY27 grant from the University of Kansas Medical Research Center Institute for $50,000. ...
Dr. Michael Wang, CBID graduate, honored as KU Spotlight on Faculty Excellence honorees announced for the 2026-27 year
This academic year, the KU Spotlight on Faculty Excellence program will celebrate 12 University of Kansas faculty and their contributions in research, scholarship and creative activity. Each honoree will be recognized during an upcoming KU Athletics event. ...
Hutchison, CBID graduate, selected for signature program Senior Administrative Fellows cohort.
Ten faculty members have been selected to join the Senior Administrative Fellows cohort for the 2026-27 academic year. The signature KU program dates back to 1993. Through the program, fellows learn more about KU and administrative roles, engage in self-reflection and assessment of their own leadership styles and preferences, and...
Dr. Shames, CBID graduate, awarded NIH grant to work on effector-triggered immunity
Dr. Stephanie R. Shames, Ph.D., Associate Professor in the Dept. of Microbiology, Genetics, & Immunology at Michigan State University, has been granted an R01 award by National Institute of Allergy and Infectious Diseases/NIH for her project "Mechanisms of effector-mediated cell-autonomous host defense against intracellular bacterial pathogens". ...
Ackley, CBID graduate, part of collaboration awarded $1.2 million grant from the W.M. Keck Foundation
What if our current understanding of Alzheimer’s disease is incorrect? ...
Fehr granted one of 16 One KU Collaborative Research Awards
Three CBID project leaders promoted during annual promotion and tenure cycle
Study reveals common mutation linked to autoimmune diseases may protect people from viral infections
‘This Week in Virology’ podcast to be hosted and recorded at KU
Fehr named recipient of University Scholarly Achievement Award
Fehr on KU Biology's Interview With a Biologist podcast
Wang, CBID graduate, collaborates with Innovaprep LLC for new award
Zhuo Wang, Pharmaceutical Chemistry and CBID graduate, has negotiated a new $149,924 contract with Innovaprep LLC for a rapid and economical system for preparation of PFAS samples to lower the Method Detection Limit. ...
Dr. Michael Wang, CBID Pilot Project investigator, speaks about the Lab2Market Accelerator
Orozco lab overturns the idea that a “risk gene” carried by millions of people influences production of Type 1 interferon in the immune system.
A new paper from the University of Kansas overturns the idea that a “risk gene” carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system. ...
Fehr research shows human gene PARP14 could be novel target for viral diseases or immune-mediated disorders
Researchers at the University of Kansas have discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study, appearing in journal mBio, could guide development of antiviral therapies for several groups of viral infection. ...
Dr. Robin Orozco, CBID Research Project Leader
Dr. Robin Orozco is an Assistant Professor at the University of Kansas, where her lab studies how specific allelic variants affect immune responses. She talks about what we can learn from mouse models and the role of PTPN22 in antiviral immunity. (36:48)...